Lack of association between HLA-E polymorphisms and transitional cell carcinoma of the bladder

Tissue Antigens

Volumn 82, Issue 3, 2013, Pages 197-200

  Veiga Castelli, L C ^a   de Paula Cruz, A S ^b   Inacio M M ^b   Mendes Junior, C T ^a   Vianello Brondani, R ^c   Moreau, P ^d,e   Castelli, E C ^f   Donadi, E A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c EMBRAPA ARROZ E FEIJÃO   (Brazil)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITÉ PARIS DIDEROT   (France)

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Bladder carcinoma; Brazilians; Haplotypes; HLA E; Polymorphism

Indexed keywords

HLA E ANTIGEN;

BLADDER CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOSITY; HLA E GENE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSITIONAL CELL CARCINOMA;

BLADDER CARCINOMA; BRAZILIANS; HAPLOTYPES; HLA-E; POLYMORPHISM;

ALLELES; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84882676666     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12159     Document Type: Letter

References (26)

1. Castelli EC, Mendes-Junior CT, Viana de Camargo JL, Donadi EA. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 2008: 72: 149-57.
2. Braud VM, Allan DS, O'Callaghan CAet al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998: 391: 795-9.
3. Marin R, Ruiz-Cabello F, Pedrinaci S et al. Analysis of HLA-E expression in human tumors. Immunogenetics 2003: 54: 767-75.
4. Carosella ED. The tolerogenic molecule HLA-G. Immunol Lett 2011: 138: 22-4.
5. Bossard C, Bezieau S, Matysiak-Budnik T et al. HLA-E/beta2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression. Int J Cancer 2012: 131: 855-63.
6. Kren L, Fabian P, Slaby O et al. Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: possible implications. Pathol Res Pract 2012: 208: 45-9.
7. Kren L, Slaby O, Muckova K et al. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance? Neuropathology 2011: 31: 129-34.
8. Levy EM, Bianchini M, Von Euw EM et al. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer. Int J Oncol 2008: 32: 633-41.
9. Benevolo M, Mottolese M, Tremante E et al. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med 2011: 9: 184.
10. Kren L, Valkovsky I, Dolezel J et al. HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma. Diagn Pathol 2012: 7: 58.
11. Saban MR, Hellmich HL, Simpson C et al. Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. BMC Cancer 2007: 7: 204.
12. Lee N, Llano M, Carretero M et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998: 95: 5199-204.
13. Tamouza R, Busson M, Fortier C et al. HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia. Hum Immunol 2007: 68: 849-53.
14. Hirankarn N, Kimkong I, Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens 2004: 64: 588-92.
15. Hassen E, Ghedira R, Ghandri N et al. Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians. DNA Cell Biol 2011: 30: 603-9.
16. Zhang J, Pan L, Chen L, Feng X, Zhou L, Zheng S. Non-classical MHC-Iota genes in chronic hepatitis B and hepatocellular carcinoma. Immunogenetics 2012: 64: 251-8.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
18. Grimsley C, Kawasaki A, Gassner C et al. Definitive high resolution typing of HLA-E allelic polymorphisms: identifying potential errors in existing allele data. Tissue Antigens 2002: 60: 206-12.
19. Veiga-Castelli LC, Castelli EC, Mendes CT Jr et al. Non-classical HLA-E gene variability in Brazilians: a nearly invariable locus surrounded by the most variable genes in the human genome. Tissue Antigens 2012: 79: 15-24.
20. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001: 68: 978-89.
21. Qin ZS, Niu T, Liu JS. Partition-ligation-expectation- maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 2002: 71: 1242-7.
22. Rousset F. genepop'007: a complete re-implementation of the genepop software for Windows and Linux. Mol Ecol Resour 2008: 8: 103-6.
23. Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003: 278: 5082-90.
24. Tripathi P, Naik S, Agrawal S. HLA-E and immunobiology of pregnancy. Tissue Antigens 2006: 67: 207-13.
25. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011: 68: 369-95.
26. Mokni-Baizig N, Ayed K, Ayed FB et al. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia. Oncology 2001: 61: 55-8.